Antiangiogenesis drugs could make major improvement in tuberculosis treatment

Use of the same antiangiogenesis drugs that have improved treatment of some cancers could also help surmount persistent difficulties in treating tuberculosis, improving the effectiveness of drug therapy and reducing the emergence of resistant bacterial strains.